SEC Form 4 · accession 0001209191-18-046604
SURMODICS INC · SRDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph J. Stich
Officer — VP and GM, IVD
Period of report
Aug 10, 2018
Accepted (ET)
Aug 14, 2018 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000924717
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 10, 2018 | S | 100 | $67.30 | D | 53,819 | D | |
| Common StockF2 | Aug 10, 2018 | S | 200 | $68.425 | D | 53,619 | D | |
| Common StockF3 | Aug 10, 2018 | S | 1,700 | $70.0596 | D | 51,919 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018.
- F2Reflects the weighted average price of 200 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 10, 2018 with sale prices ranging from $68.40 to $68.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3Reflects the weighted average price of 1,700 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 10, 2018 with sale prices ranging from $69.55 to $70.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.